A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study
- PMID: 28254128
- DOI: 10.1016/j.jchf.2016.12.011
A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study
Abstract
Objectives: The aim of this study was to develop and validate a device-based diagnostic algorithm to predict heart failure (HF) events.
Background: HF involves costly hospitalizations with adverse impact on patient outcomes. The authors hypothesized that an algorithm combining a diverse set of implanted device-based sensors chosen to target HF pathophysiology could detect worsening HF.
Methods: The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study enrolled patients with investigational chronic ambulatory data collection via implanted cardiac resynchronization therapy defibrillators. HF events (HFEs), defined as HF admissions or unscheduled visits with intravenous treatment, were independently adjudicated. The development cohort of patients was used to construct a composite index and alert algorithm (HeartLogic) combining heart sounds, respiration, thoracic impedance, heart rate, and activity; the test cohort was sequestered for independent validation. The 2 coprimary endpoints were sensitivity to detect HFE >40% and unexplained alert rate <2 alerts per patient-year.
Results: Overall, 900 patients (development cohort, n = 500; test cohort, n = 400) were followed for up to 1 year. Coprimary endpoints were evaluated using 320 patient-years of follow-up data and 50 HFEs in the test cohort (72% men; mean age 66.8 ± 10.3 years; New York Heart Association functional class at enrollment: 69% in class II, 25% in class III; mean left ventricular ejection fraction 30.0 ± 11.4%). Both endpoints were significantly exceeded, with sensitivity of 70% (95% confidence interval [CI]: 55.4% to 82.1%) and an unexplained alert rate of 1.47 per patient-year (95% CI: 1.32 to 1.65). The median lead time before HFE was 34.0 days (interquartile range: 19.0 to 66.3 days).
Conclusions: The HeartLogic multisensor index and alert algorithm provides a sensitive and timely predictor of impending HF decompensation. (Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices [MultiSENSE]; NCT01128166).
Keywords: cardiac devices; cardiac resynchronization therapy; decompensation; diagnostics; heart failure; remote monitoring; sensors.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Easy to Predict, Difficult to Prevent.JACC Heart Fail. 2017 Mar;5(3):226-228. doi: 10.1016/j.jchf.2017.01.006. JACC Heart Fail. 2017. PMID: 28254129 No abstract available.
-
HeartlogicTM: ready for prime time?Expert Rev Med Devices. 2022 Feb;19(2):107-111. doi: 10.1080/17434440.2022.2038133. Epub 2022 Feb 12. Expert Rev Med Devices. 2022. PMID: 35129007 No abstract available.
Similar articles
-
Remote monitoring: Doomed to let down or an attractive promise?Int J Cardiol Heart Vasc. 2019 May 30;24:100380. doi: 10.1016/j.ijcha.2019.100380. eCollection 2019 Sep. Int J Cardiol Heart Vasc. 2019. PMID: 31193998 Free PMC article. Review.
-
HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: Results From the MultiSENSE Study.Circ Heart Fail. 2018 Jul;11(7):e004669. doi: 10.1161/CIRCHEARTFAILURE.117.004669. Circ Heart Fail. 2018. PMID: 30002113
-
Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report.ESC Heart Fail. 2019 Apr;6(2):308-318. doi: 10.1002/ehf2.12394. Epub 2019 Jan 11. ESC Heart Fail. 2019. PMID: 30632306 Free PMC article.
-
Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure.J Card Fail. 2022 Aug;28(8):1245-1254. doi: 10.1016/j.cardfail.2022.03.349. Epub 2022 Apr 21. J Card Fail. 2022. PMID: 35460884 Clinical Trial.
-
Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.Ont Health Technol Assess Ser. 2018 Oct 24;18(7):1-199. eCollection 2018. Ont Health Technol Assess Ser. 2018. PMID: 30443279 Free PMC article. Review.
Cited by
-
Clinical Predictive Modeling of Heart Failure: Domain Description, Models' Characteristics and Literature Review.Diagnostics (Basel). 2024 Feb 17;14(4):443. doi: 10.3390/diagnostics14040443. Diagnostics (Basel). 2024. PMID: 38396482 Free PMC article. Review.
-
Influential Factors in Remote Monitoring of Heart Failure Patients: A Review of the Literature and Direction for Future Research.Sensors (Basel). 2021 May 21;21(11):3575. doi: 10.3390/s21113575. Sensors (Basel). 2021. PMID: 34063825 Free PMC article. Review.
-
Applications of the Multisensor HeartLogic Heart Failure Monitoring Algorithm During the COVID-19 Global Pandemic.JACC Case Rep. 2020 Nov 18;2(14):2265-2269. doi: 10.1016/j.jaccas.2020.09.035. Epub 2020 Oct 12. JACC Case Rep. 2020. PMID: 33073246 Free PMC article.
-
Remote monitoring: Doomed to let down or an attractive promise?Int J Cardiol Heart Vasc. 2019 May 30;24:100380. doi: 10.1016/j.ijcha.2019.100380. eCollection 2019 Sep. Int J Cardiol Heart Vasc. 2019. PMID: 31193998 Free PMC article. Review.
-
Enhancing Heart Failure Diagnosis Accuracy and Distinguishing It From Other Pulmonary Conditions: A Retrospective Case Series Study Leveraging the HeartLogic Parameters.Cureus. 2024 Aug 1;16(8):e65949. doi: 10.7759/cureus.65949. eCollection 2024 Aug. Cureus. 2024. PMID: 39221312 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous